SEC Filing Details

Document Details

Form
3
Filing Date
Oct 16, 2023
Document Date
Oct 16, 2023
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.
Filer
PARKER GEOFFREY M.